These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 34607745)
41. Primary cytoreductive surgery and adjuvant hormonal monotherapy in women with advanced low-grade serous ovarian carcinoma: Reducing overtreatment without compromising survival? Fader AN; Bergstrom J; Jernigan A; Tanner EJ; Roche KL; Stone RL; Levinson KL; Ricci S; Wethingon S; Wang TL; Shih IM; Yang B; Zhang G; Armstrong DK; Gaillard S; Michener C; DeBernardo R; Rose PG Gynecol Oncol; 2017 Oct; 147(1):85-91. PubMed ID: 28768570 [TBL] [Abstract][Full Text] [Related]
42. A novel treatment protocol with 6 cycles of neoadjuvant chemotherapy followed by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in stage III primary ovarian cancer. Marrelli D; Petrioli R; Cassetti D; D'Ignazio A; Marsili S; Mazzei MA; Lazzi S; Roviello F Surg Oncol; 2021 Jun; 37():101523. PubMed ID: 33545658 [TBL] [Abstract][Full Text] [Related]
43. [Impact of neoadjuvant chemotherapy on the survival of patients with stage IIIc and IV epithelial ovarian cancer]. Yan X; An N; Jiang GQ; Gao M; Gao YN Zhonghua Zhong Liu Za Zhi; 2008 Apr; 30(4):298-301. PubMed ID: 18788637 [TBL] [Abstract][Full Text] [Related]
44. [Ⅱ.Comparison between Upfront Primary Debulking Surgery and Interval Debulking Surgery Following Neoadjuvant Chemotherapy for Primary Treatment of Ovarian Cancer]. Onda T Gan To Kagaku Ryoho; 2019 Feb; 46(2):236-239. PubMed ID: 30914525 [No Abstract] [Full Text] [Related]
46. Phase III randomised clinical trial comparing primary surgery versus neoadjuvant chemotherapy in advanced epithelial ovarian cancer with high tumour load (SCORPION trial): Final analysis of peri-operative outcome. Fagotti A; Ferrandina G; Vizzielli G; Fanfani F; Gallotta V; Chiantera V; Costantini B; Margariti PA; Gueli Alletti S; Cosentino F; Tortorella L; Scambia G Eur J Cancer; 2016 May; 59():22-33. PubMed ID: 26998845 [TBL] [Abstract][Full Text] [Related]
47. Timing is everything: intraperitoneal chemotherapy after primary or interval debulking surgery for advanced ovarian cancer. Lee J; Curtin JP; Muggia FM; Pothuri B; Boyd LR; Blank SV Cancer Chemother Pharmacol; 2018 Jul; 82(1):55-63. PubMed ID: 29704010 [TBL] [Abstract][Full Text] [Related]
48. A novel classification of residual disease after interval debulking surgery for advanced-stage ovarian cancer to better distinguish oncologic outcome. Manning-Geist BL; Hicks-Courant K; Gockley AA; Clark RM; Del Carmen MG; Growdon WB; Horowitz NS; Berkowitz RS; Muto MG; Worley MJ Am J Obstet Gynecol; 2019 Oct; 221(4):326.e1-326.e7. PubMed ID: 31082382 [TBL] [Abstract][Full Text] [Related]
49. Adjuvant Chemotherapy May Not Be Necessary for Women with Stage IC1 Epithelial Ovarian Cancer. Deng DM; Liao QY; Yang J; Chen J; Chen G; Bai HL; Zhang B; Li KZ Curr Med Sci; 2022 Feb; 42(1):192-200. PubMed ID: 34755262 [TBL] [Abstract][Full Text] [Related]
50. Trends in surgical complexity and treatment modalities utilized in the management of ovarian cancer in an era of neoadjuvant chemotherapy. Horner W; Peng K; Pleasant V; Brackmann M; Ebott J; Gutfreund R; McLean K; Reynolds RK; Uppal S Gynecol Oncol; 2019 Aug; 154(2):283-289. PubMed ID: 31196575 [TBL] [Abstract][Full Text] [Related]
51. [Re-evaluation of interval debulking surgery in advanced epithelial ovarian cancer]. Ma Y; Li Y; Cui H; Liang XD; Tang ZJ; Li XP; Zhao Y; Wei LH Zhonghua Fu Chan Ke Za Zhi; 2012 May; 47(5):355-60. PubMed ID: 22883524 [TBL] [Abstract][Full Text] [Related]
52. Neoadjuvant chemotherapy (NACT) is an effective way of managing elderly women with advanced stage ovarian cancer (FIGO Stage IIIC and IV). Glasgow MA; Yu H; Rutherford TJ; Azodi M; Silasi DA; Santin AD; Schwartz PE J Surg Oncol; 2013 Feb; 107(2):195-200. PubMed ID: 22648987 [TBL] [Abstract][Full Text] [Related]
53. Cytoreductive surgery followed by chemotherapy versus chemotherapy alone for recurrent platinum-sensitive epithelial ovarian cancer (SOCceR trial): a multicenter randomised controlled study. van de Laar R; Zusterzeel PL; Van Gorp T; Buist MR; van Driel WJ; Gaarenstroom KN; Arts HJ; van Huisseling JC; Hermans RH; Pijnenborg JM; Schutter EM; Pelikan HM; Vollebergh JH; Engelen MJ; Inthout J; Kruitwagen RF; Massuger LF BMC Cancer; 2014 Jan; 14():22. PubMed ID: 24422892 [TBL] [Abstract][Full Text] [Related]
54. Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer. Winter-Roach BA; Kitchener HC; Dickinson HO Cochrane Database Syst Rev; 2009 Jan; (1):CD004706. PubMed ID: 19160239 [TBL] [Abstract][Full Text] [Related]
55. Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer. Winter-Roach BA; Kitchener HC; Dickinson HO Cochrane Database Syst Rev; 2009 Jul; (3):CD004706. PubMed ID: 19588360 [TBL] [Abstract][Full Text] [Related]
56. [Value of CA(125) in the prediction of optimal interval debulking surgery and its prognosis in patients with epithelial ovarian cancer]. Mu T; Li XP; Wang JL; Wang SJ; Wang Y; Sun XL; Cui H; Wei LH Zhonghua Fu Chan Ke Za Zhi; 2012 Aug; 47(8):566-70. PubMed ID: 23141174 [TBL] [Abstract][Full Text] [Related]
57. Role of neoadjuvant chemotherapy in the management of advanced ovarian cancer. Zhao D; Wu LY; Wang XB; Li XG Asian Pac J Cancer Prev; 2015; 16(6):2369-73. PubMed ID: 25824766 [TBL] [Abstract][Full Text] [Related]
58. Association Between Overall Survival and the Tendency for Cancer Programs to Administer Neoadjuvant Chemotherapy for Patients With Advanced Ovarian Cancer. Melamed A; Rauh-Hain JA; Gockley AA; Nitecki R; Ramirez PT; Hershman DL; Keating N; Wright JD JAMA Oncol; 2021 Dec; 7(12):1782-1790. PubMed ID: 34591081 [TBL] [Abstract][Full Text] [Related]
59. Effect of neoadjuvant chemotherapy on platinum resistance in stage IIIC and IV epithelial ovarian cancer. Luo Y; Lee M; Kim HS; Chung HH; Song YS Medicine (Baltimore); 2016 Sep; 95(36):e4797. PubMed ID: 27603388 [TBL] [Abstract][Full Text] [Related]
60. Platinum-Based Neoadjuvant Chemotherapy versus Primary Surgery in Ovarian Carcinoma International Federation of Gynecology and Obstetrics Stages IIIc and IV: A Systematic Review and Meta-Analysis. Xiao Y; Xie S; Zhang N; Wang J; Lv C; Guo J; Yang Q Gynecol Obstet Invest; 2018; 83(3):209-219. PubMed ID: 29402804 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]